Matrixx Initiatives 8-K 2005
WASHINGTON, DC 20549
CURRENT REPORT PURSUANT
Date of report (Date of earliest event reported) May 18, 2005
MATRIXX INITIATIVES, INC.
(Exact Name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction of Incorporation)
(Registrants Telephone Number, Including Area Code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Item 8.01. Other Events
On May 18, 2005, Matrixx Initiatives, Inc. issued a press release announcing Zicam® product line extensions and improvements. A copy of the press release is attached to this Report as Exhibit 99.1
Item 9.01. Financial Statements and Exhibits
99.1 Press Release of Matrixx Initiatives, Inc. dated May 18, 2005 entitled Matrixx Initiatives, Inc. Announces Zicam® Product Line Extensions; Zicam Intense Cold & Flu Relief, Zicam Cough Mist Max.
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 18, 2005